Top Analysts
Which analyst reports would you recommend looking at? Anyone who's had particularly good predictions for the past couple of years?
Which analyst reports would you recommend looking at? Anyone who's had particularly good predictions for the past couple of years?
+81 | Q&A - Buyside Equity Research Analyst/PM | 29 | 5d | |
+32 | How the heck do you learn all of this stuff? | 10 | 11h | |
+28 | Getting Frustrated | 10 | 4w | |
+28 | My experience on the sell side | 20 | 2w | |
+24 | Clues in Financial Reporting Analysis | 7 | 2d | |
+17 | Am i fairly compensated? | 9 | 3d | |
+14 | Data Science to PM | 8 | 1w | |
+14 | Heard they don’t model at Oppenheimer | 10 | 2w | |
+12 | ER - Remote Jobs? | 8 | 5d | |
Equity Research at Bank vs IG, High Yield & Leveraged Loans Research at Asset Manager | 4 | 1d |
Career Resources
interested in others' opinions too. Lets break it down by industry.
Interested in any respected healthcare (MedTech and Lifesciences specifically) Analysts
buyside or sellside? Different agendas and also obv buyside lets visibility on their calls.
either! not picky on any insight. appreciate it
MedTech: Morgan Stanley, BAML, and Evercore top 3
Life Science: JPM and BAML are 1/2....idk who is 3 (used to be Evercore)
These are by II rank
I'd argue that platform matters over analyst. Just stick to BB with a bias to the banks with fancier banking reputations. Most of the "insight" generated by these guys is more network and less primary research, though I've seen some good stuff come from the Pipers and Jefcos of the world, especially in HC.
This is amazing. Thanks ES. I recently talked with an alum at BofA in HC, and he mentioned that their MedTech banking team is top on the street.
Also, what's LL rank? Not familiar with the acronym.
This 100% makes sense. From what I've gathered, buysiders mostly utilize the network/corporate access that a given analyst/bank has; using the research as mostly insight and not putting too much weight on it.Side note, do you cover HC? Seems like it.
Any info on Pharma or Biotech analysts?
Tusa's call on GE is probably the best one from my coverage. Also had a decent call on 3M.
check out tipranks.com
Stock price predictions don't matter very much in Sellside ER. There's a reason the people at the top of TipRanks are all from shitty firms. Also, Buyside firms that just piggyback off of sellside calls are typically shitty funds. Here's a direct quote from an II-ranked MD at a BB, "My price target is usually the least important thing on my report."
People who use Tipranks have no idea how to properly use sellside research.
What makes a great SS analyst then if their stock price predictions don't matter much, and conversely what makes a SS analyst terrible? Trying to learn more about the industry so would really appreciate a response, I literally thought that a SS analyst trying to have the closest calls in price targets is what made them respected/useful.
Also makes a lot of sense now why so many SS analysts stay on the sell-side instead of moving to the buy-side, seems like a very safe gig if you don't even have to have good predictions
I don't disagree, but OP specifically asked about who has had good predictions for the past couple of years and TipRanks does aggregate that data. If you are on the buy side and have access to the actual reports, the last thing you should be looking at is the price target.
Just check Bloomberg Absolute Return Rank and Portfolio BARR Ranking.
.
Bruno Monteyne - Bernstein. Covers consumer and is frequently cited in FT & economist. very well respected.
I'll add for the Media / Entertainment & Telecom space:
Best Overall: Craig Moffett & Michael Nathanson (MN) Ben Swinburne (MS) Vijay Jayant / John Belton (Evercore ISI)
Hit or Miss by individual piece or name: Rich Greenfield (Lightshed TMT) Jessica Reif (BofA) Alexia Quadrani (JPM)
Consistently Bad: Jason Bazinet (Citi)
What names are Rich good on? Agreed on list overall.
Modi rerum maxime repellat suscipit. Nobis tempore inventore eum et expedita voluptas. Quisquam rerum sed mollitia ratione soluta. Ea architecto unde sed ullam esse sint. Voluptate illo dignissimos aut natus.
Pariatur aut rerum unde iure rem nemo quam. Ratione et eaque enim sunt.
Atque perferendis magnam tempore velit atque. Neque qui distinctio commodi itaque fugit eos cupiditate. Sed aut voluptas labore quisquam odio beatae et consequatur. Ut nobis eum et quae animi qui saepe. Accusantium praesentium quidem sint vero.
Maiores sed aut dolor. Quia cum exercitationem sit nemo rerum eligendi ipsam. Qui est dolorem sint assumenda laboriosam. Eaque eum maiores vel animi nisi numquam voluptatibus quod. Accusantium dolores facilis aut et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...